Chromosomal instability and double minute chromosomes in a breast cancer patient

Acta Medica Okayama

Volumn 58, Issue 1, 2004, Pages 51-58

  Lalić, Hrvoje ^a   Volavšek, Črtomir ^b   Radošević Stašić, Biserka ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b Center for Environmental Health   (Slovenia)

Author keywords

Breast carcinoma; Chromosomal instability; Double minutes; Ionizing radiation

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; TAMOXIFEN CITRATE;

ADULT; ARTICLE; BLOOD EXAMINATION; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER RADIOTHERAPY; CASE REPORT; CHROMATID ABERRATION; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME DAMAGE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; DOUBLE MINUTE CHROMOSOME; FEMALE; GENETIC STABILITY; HOSPITAL PERSONNEL; HUMAN; IONIZING RADIATION; OCCUPATIONAL HAZARD; PERIPHERAL LYMPHOCYTE; RADIATION EXPOSURE;

BREAST NEOPLASMS; CARCINOMA; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RADIATION, IONIZING;

EID: 1842579223     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Lengauer C, Kinzler KW and Vogelstein B: Genetic instabilities in human cancers. Nature (1998) 396: 643-649.
2. Nathanson KL, Wooster R, Weber BL and Nathanson KN: Breast cancer genetics: What we know and what we need. Nat Med (2001) 7: 552-556.
3. Cross CK, Harris J and Recht A: Race, socioeconomic status, and breast carcinoma in the U.S: What have we learned from clinical studies. Cancer (2002) 95: 1988-1999.
4. Claus EB, Risch N and Thompson WD: Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer (1994) 73: 643-651.
5. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod P, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Golgar D, Wiseman R, Kamb A and Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCAI. Science (1994) 266: 66-71.
6. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormison W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE and Stratton MR: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (1994) 265: 2088-2090.
7. Frank TS and Skolnick MH: Testing for hereditary cancer risk: Pandora or Prometheus? J. Clin Endocrinol Metab (1999) 84: 1882-1885.
8. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC and Tucker MA: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 336: 1401-1408.
9. Tomlinson IP, Novelli MR and Bodmer WF: The mutation rate and cancer. Proc Natl Acad Sci USA (1996) 93: 14800-14803.
10. Venkitaraman AR: Functions of BRCAI and BRCA2 in the biological response to DNA damage. J Cell Sci (2001) 114: 3591-3598.
11. Loeb KR and Loeb LA: Significance of multiple mutations in cancer. Carcinogenesis (2000) 21: 379-385.
12. Karran P: DNA double strand break repair in mammalian cells. Curr Opin Genet Dev (2000) 10: 144-150.
13. Carbonell E, Demopoulos NA, Stefanou G, Psaraki K, Parry KM and Marcos R: Cytogenetic analysis in peripheral lymphocytes of cancer patients treated with cytostatic drugs: Results from an EC Collaborative Study. Anticancer Drugs (1996) 7: 514-519.
14. Baciuchka-Palmaro M, Orsiere T, Duffaud F, Sari-Minodier I, Pompili J, Bellon L, De Meo M, Digue L, Favre R and Botta A: Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patients. Mutat Res (2002) 520: 189-198.
15. Rigaud O, Guedeney G, Duranton I, Leroy A, Doloy MT and Magdelenat H: Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. II. Alteration of DNA repair and chromosome radiosensitivity. Mutat Res (1990) 242: 25-35.
16. Hendry JH: Genomic instability: Potential contributions to tumour and normal tissue response, and second tumours, after radiotherapy. Radiother Oncol (2001) 59: 117-126.
17. Legal JD, De Crevoisier R, Lartigau E, Morsli K, Dossou J, Chavaudra N, Sanfilippo N, Bourhis J, Eschwege F and Parmentier C: Chromosomal aberrations induced by chemotherapy and radiotherapy in lymphocytes from patients with breast carcinoma. Int J Radiat Oncol Biol Phys (2002) 52: 1186-1195.
18. Barber JB, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA and Scott D: Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol (2000) 55: 179-186.
19. Kasuba V, Sentija K, Garaj-Vrhovac V and Fučić A: Chromosome aberrations in peripheral blood lymphocytes from control individuals. Mutat Res (1995) 346: 187-193.
20. Lalić H, Lekić A and Radoševic-Stašić B: Comparison of chromosome aberrations in peripheral blood lymphocytes from people occupationally exposed to ionizing and radiofrequency radiation. Acta Med Okayama (2001) 55: 117-127.
21. Awa AA and Neel JV: Cytogenetic "rogue" cells: What is their frequency, origin, and evolutionary significance? Proc Natl Acad Sci USA (1986) 83: 1021-1025.
22. Hahn PJ: Molecular biology of double-minute chromosomes. Bioessays (1993) 15: 477-484.
23. Neel JV, Major EO, Awa AA, Glover T, Burgess A, Traub R, Curfman B and Satoh C: Hypothesis: "Rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implications for oncogenesis. Proc Natl Acad Sci USA (1996) 93: 2690-2695.
24. Rozgaj R, Kasuba V and Simić D: The frequency of dicentrics and acentrics and the incidence of rogue cells in radiation workers. Mutagenesis (2002) 17: 135-139.
25. Domracheva EV, Rivkind NB, Aseeva EA, Obukhova TN, D'achenko LV and Vorobiov Al: Stable and unstable aberrations in lymphocytes of Chernobyl accident clearance workers carrying rogue cells. Appl Radiat Isot (2000) 52: 153-1159.
26. Neel JV: An association, in adult Japanese, between the occurrence of rogue cells among cultured lymphocytes (JC virus activity) and the frequency of "simple" chromosomal damage among the lymphocytes of persons exhibiting these rogue cells. Am J Hum Genet (1998) 63: 489-497.
27. Testard I, Ricoul M, Hoffschir F, Flury-Herard A, Dutrillaux B, Fedorenko B, Gerasimenko V and Sabatier L: Radiation-induced chromosome damage in astronauts' lymphocytes. Int J Radiat Biol (1996) 70: 403-411.
28. Obe G, Johannes I, Johannes C, Hallman K, Reitz G and Facius R: Chromosomal aberrations in blood lymphocytes of astronauts after long-term space flights. Int J Radiat Biol (1997) 72: 727-734.
29. Michalova K, Cermak J, Brezinova J and Zemanova Z: Double minute chromosomes in a patient with myelodysplastic syndrome transforming into acute myeloid leukemia. Cancer Genet Cytogenet (1999) 109: 76-78.
30. Mathew S, Lorsbach RB, Shearer P, Sandlund JT and Raimondi SC: Double minute chromosomes and c-MYC amplification in a child with secondary myelodysplastic syndrome after treatment for acute lymphoblastic leukemia. Leukemia (2000) 14: 1314-1315.
31. Govberg IJ, Wolf JL and Cotter PD: Trisomy 4 and double minutes in acute myeloid leukemia: Further evidence that double minutes can occur as the primary cytogenetic abnormality. Cancer Genet Cytogenet (2000) 121: 212-215.
32. Streubel B, Valent P, Jager U, Edelhauser M, Wandt H, Wagner T, Buchner T, Lechner K and Fonatsch C: Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosomes Cancer (2000) 27: 380-386.
33. Sait SN, Qadir MU, Conroy JM, Matsui S, Nowak NJ and Baer MR: Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: Identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer (2002) 34: 42-47.
34. Streubel B, Valent P, Jager U, Edelhauser M, Wandt H, Wagner T, Buchner T, Lechner K and Fonatsch C: Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosomes Cancer (2000) 27: 380-386.
35. O'Malley F, Rayeroux K, Cole-Sinclair M, Tong M and Campbell LJ: MYC amplification in two further cases of acute myeloid leukemia with trisomy 4 and double minute chromosomes. Cancer Genet Cytogenet (1999) 109: 123-125.
36. Sambani C, Trafalis DT, Vessalas G, Politis G, Peristeris P, Nakopoulou L, Giannopoulou J, Michaelidis C, Ayoutantis M and Pantelias GE: Trisomy 6 and double minute chromosomes in a case of chronic myelomonocytic leukemia. Cancer Genet Cytogenet (1998) 106: 180-181.
37. Bruckert P, Kappler R, Scherthan H, Link H, Hagmann F and Zankl H: Double minutes and c-MYC amplification in acute myelogenous leukemia: Are they prognostic factors? Cancer Genet Cytogenet (2000) 120: 73-79.
38. Dave BJ, Hopwood VL, King TM, Jiang H, Spitz MR, Pathak S and Ziang H: Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. Cancer Epidemiol Biomarkers Prev (1995) 4: 743-749. Erratum in: Cancer Epidemiol Biomarkers Prev (1995) 4: 910-938.
39. Bonassi S, Hagmar L, Stromberg U, Montagud AH, Tinnerberg H, Forni A, Heikkila P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE and Norppa H: Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res (2000) 60: 1619-1625.
40. Bonassi S, Neri M and Puntoni R: Validation of biomarkers as early predictors of disease. Mutat Res (2001) 480-481: 349-358.
41. Russell NS and Begg AC: Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage. Radiother Oncol (2002) 64: 125-129.
42. Schwab M: Oncogene amplification in solid tumors. Semin Cancer Biol (1999) 9: 319-325.
43. Herrmann ME, Lalley PA, Rydstedt LL, Meese E, Lang CH, Abumrad NN, Moll UM and Talpos GB: Double minutes in the papillary thyroid cancer cell line PTC-1113A. Cancer Genet Cytogenet (1996) 90: 70-74.
44. Agamanolis DP and Malone JM: Chromosomal abnormalities in 47 pediatric brain tumors. Cancer Genet Cytogenet (1995) 81: 125-134.
45. Takami S, Kawasome C, Kinoshita M, Koyama H and Noguchi S: Chromosomal instability detected by fluorescence in situ hybridization in Japanese breast cancer patients. Clin Chim Acta (2001) 308: 127-131.
46. Rennstam K, Baldetorp B, Kytola S, Tanner M and Isola J: Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer. Cancer Res (2001) 61: 1214-1219.
47. Berenberg JL: Response to treatment of breast cancer. Breast Cancer Res Treat (1991) 18: S147-S155.
48. Zhang GJ, Tsuda H, Adachi I, Fukutomi T, Yamamoto H and Hirohashi S: Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins. Jpn J Clin Oncol (1997) 27: 371-377.
49. Mizukami Y, Nonomura A, Takizawa T, Noguchi M, Michigishi T, Nakamura S and Ishizaki T: N-myc protein expression in human breast carcinoma: Prognostic implications. Anticancer Res (1995) 15: 2899-2905.
50. Jaworowski Z: Beneficial effects of radiation and regulatory policy. Australas Phys Eng Sci Med (1997) 20: 125-138.
51. Bianchi NO, Bianchi MS and Richard SM: Mitochondrial genome instability in human cancers. Mutat Res (2001) 488: 9-23.
52. Kramer M, Stein B, Mai S, Kunz E, Konig H, Loferer H, Grunicke HH, Ponta H, Herrlich P and Rahmsdorf HJ: Radiation-induced activation of transcription factors in mammalian cells. Radiat Environ Biophys (1990) 29: 303-313.
53. Fornace AJ Jr: Mammalian genes induced by radiation; activation of genes associated with growth control. Annu Rev Genet (1992) 26: 507-526.
54. Walinder G: When are animal experiments necessary? Factors of significance to the development of radiogenic bone tumors. Radiat Environ Biophys (1991) 30: 229-231.
55. Mothersill C, Seymour CB and Joiner MC: Relationship between radiation-induced low-dose hypersensitivity and the bystander effect. Radiat Res (2002) 157: 526-532.
56. Little JB, Azzam EI, de Toledo SM and Nagasawa H: Bystander effects: Intercellular transmission of radiation damage signals. Radiat Prot Dosimetry (2002) 99: 159-162.
57. Barcellos-Hoff MH and Brooks AL: Extracellular signaling through the microenvironment: A hypothesis relating carcinogenesis, bystander effects, and genomic instability. Radiat Res (2001) 156: 618-627.
58. Albanese J and Dainiak N: Modulation of intercellular communication mediated at the cell surface and on extracellular, plasma membrane-derived vesicles by ionizing radiation. Exp Hematol (2003) 31: 455-464.
59. Donaldson SS, Hancock SL and Hoppe RT: The Janeway lecture. Hodgkin's disease-finding the balance between cure and late effects. Cancer J Sci Am (1999) 5: 325-333.
60. Lalić H, Radošević-Stašić B and Volavšek Č: High incidence of chromosome aberrations after radiochemotherapy for Hodkin's disease: A report of a case and a review of the literature. Folia Biol (Praha) (2001) 47: 101-105.
61. Clemons M, Loijens L and Goss P: Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev (2000) 26: 291-302.
62. Nayak BN, Sokal J and Ray M: Clonal chromosomal changes in chronic lymphocytic leukemia. Cancer Lett (1990) 49: 99-105.
63. Linassier C, Barin C, Calais G, Letortorec S, Bremond JL, Delain M, Petit A, Georget MT, Cartron G, Raban N, Benboubker L, Leloup R, Binet C, Lamagnere JP and Colombat P: Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. Ann Oncol (2000) 11: 1289-1294.
64. Madhavi R, Guntur M, Ghosh R and Ghosh PK: Double minute chromosomes in the leukocytes of a young girl with breast carcinoma. Cancer Genet Cytogenet (1990) 44: 203-207.